BCAT1 Antikörper
-
- Target Alle BCAT1 Antikörper anzeigen
- BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
-
Reaktivität
- Human, Maus, Hund
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCAT1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- Homo sapiens branched chain amino-acid transaminase 1, cytosolic (BCAT1), transcript variant 1
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human BCAT1(NP_005495) produced in HEK293T cell.
- Klon
- 3F5
- Isotyp
- IgG2a
- Top Product
- Discover our top product BCAT1 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500~2000, IHC 1:150,
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
-
BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients." in: Scientific reports, Vol. 7, Issue 1, pp. 17740, (2017) (PubMed).
: "Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia." in: Nature, Vol. 545, Issue 7655, pp. 500-504, (2017) (PubMed).
: "
-
BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients." in: Scientific reports, Vol. 7, Issue 1, pp. 17740, (2017) (PubMed).
-
- Target
- BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
- Andere Bezeichnung
- BCAT1 (BCAT1 Produkte)
- Synonyme
- fj66g02 antikoerper, zgc:73157 antikoerper, wu:fj66g02 antikoerper, Bcatc antikoerper, BCATC antikoerper, BCT1 antikoerper, ECA39 antikoerper, MECA39 antikoerper, PNAS121 antikoerper, PP18 antikoerper, BCATc antikoerper, Eca39 antikoerper, branched chain amino-acid transaminase 1, cytosolic antikoerper, branched chain amino acid transaminase 1 antikoerper, branched chain amino-acid transaminase 1, cytosolic L homeolog antikoerper, branched chain aminotransferase 1, cytosolic antikoerper, bcat1 antikoerper, BCAT1 antikoerper, bcat1.L antikoerper, Bcat1 antikoerper
- Hintergrund
- This gene encodes the cytosolic form of the enzyme branched-chain amino acid transaminase. This enzyme catalyzes the reversible transamination of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamination: hypervalinemia and hyperleucine-isoleucinemia. As there is also a gene encoding a mitochondrial form of this enzyme, mutations in either gene may contribute to these disorders. Alternatively spliced transcript variants have been described.
- Molekulargewicht
- 42.8 kDa
- Gen-ID
- 586
- NCBI Accession
- NM_005504
- HGNC
- 586
-